文献速递前列腺癌

高危前列腺癌:放疗与手术策略的头对头比较

Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer.
PubMed 文献 · Eur Urol Oncol · 2025-07-19

基于NRG/RTOG 0521与CALGB 90203两项随机对照试验的个体患者数据,比较高危前列腺癌放疗为基础与根治性前列腺切除术为基础的治疗策略。经逆概率加权后,放疗组8年远处转移累积发生率显著低于手术组(15% vs 22%,sHR 0.58,P=0.001),但远处转移后死亡风险两组无显著差异。

要点

  • 放疗为基础策略较高危前列腺癌手术策略显著降低8年远处转移累积发生率。
  • 远处转移后死亡风险两组相似,调整sHR 0.98(95%CI 0.61-1.58)。
  • 手术组患者预后特征更优且更年轻,需经IPTW校正后比较。

核心结论

  • 高危前列腺癌患者接受放疗为基础的治疗策略较根治性前列腺切除术为基础策略显著降低远处转移累积发生率,而远处转移后死亡风险两组相似。

研究设计与样本

  • 利用NRG/RTOG 0521(放疗为基础,2005-2009年入组)与CALGB 90203(手术为基础,2006-2015年入组)两项北美合作组3期随机对照试验的个体患者数据,共纳入1290例新诊断高危前列腺癌患者(放疗组557例,手术组733例)。
  • 采用逆概率治疗加权(IPTW)比较远处转移累积发生率,并将死亡作为竞争事件。
  • 放疗组接受放疗联合24个月雄激素剥夺治疗(ADT)±6周期辅助多西他赛;手术组接受根治性前列腺切除术联合个体化术后治疗±6周期新辅助多西他赛及18-24周ADT。

主要发现

  • 中位随访时间放疗组6.4年(IQR 5.6-6.9),手术组6.4年(IQR 4.7-8.5)。
  • 手术组患者整体预后特征更优且更年轻。
  • IPTW后,放疗组8年远处转移累积发生率为15%(95%CI 9.3-21),手术组为22%(95%CI 18-26),调整亚分布风险比(sHR)0.58(95%CI 0.42-0.81),P=0.001。
  • 远处转移后死亡发生率两组无显著差异,调整sHR 0.98(95%CI 0.61-1.58)。

临床怎么用

  • 对于高危前列腺癌患者,放疗为基础的治疗策略在降低远处转移方面可能优于手术为基础策略,但需结合患者特征个体化选择。
  • 远处转移后死亡风险两组相似,提示两种策略对转移后生存的影响可能相当。

局限性

  • 研究基于两项不同随机对照试验的个体患者数据比较,非直接头对头随机比较,存在未测量混杂可能。
  • 手术组患者预后特征更优且更年轻,尽管采用IPTW校正,仍可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Optimal management for high-risk prostate cancer is unclear. Using individual patient data from two contemporaneous North American cooperative group phase 3 randomized controlled trials (RCTs), we compared the outcomes of high-risk prostate cancer patients treated with radiotherapy-based and radical prostatectomy (RP)-based treatment strategies. METHODS: Data were collected from newly diagnosed high-risk prostate cancer patients enrolled in NRG/RTOG 0521 who received radiotherapy-based treatment (2005-2009), and those enrolled in CALGB 90203 who received surgery-based treatment (2006-2015). Patients received radiotherapy plus 24 mo of androgen deprivation therapy (ADT) ± six cycles of adjuvant docetaxel versus RP with personalized postoperative therapy ± neoadjuvant six cycles of docetaxel and 18-24 wk of ADT. The primary objective was to compare the cumulative incidence of distant metastasis considering death as a competing event using the inverse probability of treatment weighting (IPTW). KEY FINDINGS AND LIMITATIONS: Overall, 1290 patients (radiotherapy n = 557, RP n = 733) were included with similar follow-up (median 6.4 [interquartile range {IQR}: 5.6-6.9] yr and 6.4 [IQR: 4.7-8.5] yr, respectively). Patients who received surgery had generally more favorable prognostic features and were younger relative to those who received radiotherapy. After IPTW, the cumulative incidence of distant metastasis was significantly lower in patients who underwent radiotherapy-based compared with RP-based treatment (8-yr distant metastasis: 15% [95% confidence interval {CI} 9.3-21] vs 22% [95% CI 18-26]; adjusted subdistribution hazard ratio [sHR] 0.58 [95% CI 0.42-0.81]; p = 0.001). We did not find any significant difference in the incidence of deaths after distant metastasis (adjusted sHR 0.98 [95% CI 0.61-1.58]) between the two groups. CONCLUSIONS AND CLINICAL IMPLICATIONS: High-risk prostate cancer patients enrolled in RCTs had a significantly lower incidence of distant metastasis with a radiotherapy-based treatment strategy than with an RP-based treatment strategy, while the risk of deaths after distant metastasis was similar in the two groups.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Roy S, Sun Y, Eastham JA, et al. Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer. Eur Urol Oncol. 2025. PMID: 40683825. doi:10.1016/j.euo.2025.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。